stella
beta
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients — Stella
Recruiting
Back to End-Stage Renal Disease Requiring Haemodialysis trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Peking University People's Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov